Asthma Alert: Are Your Genes Making You Wheeze?
"New Research Links Specific Gene Variations to Increased Asthma Risk"
Asthma, a chronic inflammatory disease affecting millions worldwide, is characterized by airway obstruction and hyperresponsiveness. While environmental factors play a significant role, genetics are increasingly recognized as a key contributor, with heritability estimates as high as 79%. Understanding the genetic components of asthma can pave the way for more targeted and effective treatments.
Vascular endothelial growth factor (VEGF) is a potent angiogenic factor known for its role in endothelial cell proliferation and influencing the behavior of epithelial cells and fibroblasts. VEGF is crucial in Th2-mediated inflammation and airway remodeling, processes that contribute to the development of asthma. Studies have shown elevated VEGF levels in the bronchoalveolar lavage fluid and sputum of asthmatic individuals, suggesting a strong link between VEGF and asthma.
Recent research has focused on identifying specific polymorphisms—variations in DNA sequences—within the VEGF gene that might influence asthma susceptibility. A study exploring the relevance of VEGF gene polymorphisms in a Chinese Han population identified significant associations between specific SNPs (single nucleotide polymorphisms) and the occurrence of asthma, shedding light on potential genetic risk factors.
VEGF as a Treatment-Response Hypothesis
A May 30, 2021 article predicts that variants in VEGF genes could be associated with asthma treatment response, based on evidence that inhibiting VEGF diminishes asthma symptoms in mice. A 2011 review also reports that asthma treatment decreases VEGF levels and that VEGF inhibition diminishes asthma symptoms. These findings provide a research rationale for studying VEGF, but the cited material does not establish a validated clinical test or treatment protocol based on VEGF variants.
A Slow, Complex Genetic Picture
A review of the genomic origins of asthma notes that human lung development begins at approximately the fourth week of gestation and continues into the post-natal period. It describes asthma as heritable but says progress in defining its genetic underpinnings has been slow and hampered by inconsistent findings. The Annual Reviews account likewise emphasizes asthma's heritability and the difficulty caused by inconsistency in genetic research.
Decoding VEGF: How Gene Variations Impact Asthma Risk
A study published in Genetics and Molecular Research investigated the association between single nucleotide polymorphisms (SNPs) in the VEGF gene and asthma in a Chinese Han population. The researchers extracted DNA from 471 participants, including 226 asthma patients and 245 healthy controls, and analyzed seven specific SNPs within the VEGF gene using the MassARRAY system. The goal was to determine if certain genetic variations were more prevalent in individuals with asthma compared to those without.
- rs3025020 and rs3025039: Showed significant differences in genotype frequencies between asthma patients and healthy controls.
- T Alleles: The T alleles of rs3025020 and rs3025039 were more common in individuals with asthma.
- VEGF Gene: These SNPs are located within the vascular endothelial growth factor gene, which plays a crucial role in airway inflammation and remodeling.
New Genomic and Pharmacogenomic Directions
A May 29, 2025 review examines how pharmacogenetic variables and gene therapies may affect responsiveness to asthma therapy. A separate study published November 1, 2025, describes a multi-omic approach combining genome-wide association study (GWAS) data with single-cell chromatin accessibility profiles from fetal lung tissue to investigate asthma's genetic architecture. The supplied summaries describe these research approaches, but do not report specific findings from either one.
Association Signals Have Limits
In a study of Tunisian children, the VEGF −634 G > C polymorphism showed only a borderline association with asthma for the G allele (p = 0.059). The study found no statistically significant differences for the +936 C > T or −2549 −2567 del 18 polymorphisms between asthma patients and controls. Separately, a multi-ancestry study of asthma exacerbations notes that combining reports covering the previous 6 to 24 months with reports of exacerbations ever may have introduced phenotype heterogeneity.
Shared Genetics Across Asthma Subtypes
A multi-ancestry meta-analysis reports a genetic correlation of 0.78 (SE 0.30; p = 1.32 × 10⁻¹¹⁶) between its childhood-onset asthma (COA) and adult-onset asthma (AOA) analyses. The authors say this was similar to a previously reported correlation of 0.67 (SE 0.02) between asthma age-of-onset subtypes. They also observed substantial overlap between the top loci in each subtype meta-analysis and those in the all-asthma meta-analysis.
What Does This Mean for Asthma Management?
The identification of specific VEGF gene polymorphisms associated with asthma opens new avenues for understanding the pathogenesis of this complex condition. While further research is needed to fully elucidate the functional implications of these genetic variations, these findings suggest that genetic screening and personalized medicine approaches may play a future role in asthma management. Individuals with a family history of asthma may benefit from genetic testing to assess their risk and tailor preventive strategies accordingly. As our understanding of the genetic basis of asthma expands, we can move towards more targeted and effective interventions, improving outcomes for individuals affected by this chronic respiratory disease.
Considering Prenatal and Postnatal Exposures
A review dated July 1, 2026, focuses on gene–environment interactions in childhood asthma. It summarizes environmental exposure factors during prenatal and postnatal periods and analyzes their independent effects on childhood asthma risk. Its stated scope highlights exposures as an important part of the discussion, alongside the genetic questions raised by the article.
Toward Personalized Asthma Management
The article “Asthma Alert: Are Your Genes Making You Wheeze?” presents VEGF gene variations as a possible influence on the likelihood of developing asthma. It points to genetic risk factors and personalized asthma management as topics for further attention. The supplied description frames this as potential influence, not as a proven way to predict or manage an individual's asthma.